These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. Turbyfill KR; Kaminski RW; Oaks EV Vaccine; 2008 Mar; 26(10):1353-64. PubMed ID: 18276045 [TBL] [Abstract][Full Text] [Related]
45. Microfluidic chip analysis of outer membrane proteins responsible for serological cross-reaction between three Gram-negative bacteria: Proteus morganii O34, Escherichia coli O111 and Salmonella Adelaide O35. Péterfi Z; Kustos I; Kilár F; Kocsis B J Chromatogr A; 2007 Jul; 1155(2):214-7. PubMed ID: 17362972 [TBL] [Abstract][Full Text] [Related]
46. Immunoproteomics of membrane proteins of Shigella flexneri 2a 2457T. Ying TY; Wang JJ; Wang HL; Feng EL; Wei KH; Huang LY; Huang PT; Huang CF World J Gastroenterol; 2005 Nov; 11(43):6880-3. PubMed ID: 16425402 [TBL] [Abstract][Full Text] [Related]
47. Bacteriological and epidemiological approaches to the prophylaxis of enteric infection. VI. In vitro studies on the mechanism of acquired resistance to Shigella flexneri infection (1). Sakaguchi T; Sakaguchi S; Okamoto M; Matsui S; Anzai H Kitasato Arch Exp Med; 1980 Dec; 53(3-4):97-109. PubMed ID: 7035741 [No Abstract] [Full Text] [Related]
48. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5. Zhou M; Guo Y; Zhao J; Hu Q; Hu Y; Zhang A; Chen H; Jin M Vaccine; 2009 Aug; 27(38):5271-7. PubMed ID: 19576561 [TBL] [Abstract][Full Text] [Related]
49. [Increased sensitivity of immune macrophages to the cytotoxic action of virulent shigellae]. Belaia IuA; Popova LIu; Bystrova SM; Nikolaeva TN Zh Mikrobiol Epidemiol Immunobiol; 1982 Jul; (7):69-73. PubMed ID: 6750996 [TBL] [Abstract][Full Text] [Related]
50. Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach. Li H; Xiong XP; Peng B; Xu CX; Ye MZ; Yang TC; Wang SY; Peng XX J Proteome Res; 2009 Sep; 8(9):4342-9. PubMed ID: 19640004 [TBL] [Abstract][Full Text] [Related]
52. [Mapping of diagnostically important antigenic regions of major outer membrane protein (MOMP) from Chlamydia trachomatis using recombinant proteins with overlapping structures]. Savel'eva NV; Zagriadskaia IuE; Klimashevskaia SV; Puzyrev VF; Burkov AN; Obriadina AP; Ulanova TI Mol Gen Mikrobiol Virusol; 2009; (3):17-21. PubMed ID: 19705778 [TBL] [Abstract][Full Text] [Related]
53. Assessment of vaccine potential of the Neisseria-specific protein NMB0938. Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688 [TBL] [Abstract][Full Text] [Related]
54. The expression of lipopolysaccharide by strains of Shigella dysenteriae, Shigella flexneri and Shigella boydii and their cross-reacting strains of Escherichia coli. Chart H; Daniel RM; Cheasty T FEMS Microbiol Lett; 2009 Mar; 292(1):21-6. PubMed ID: 19222579 [TBL] [Abstract][Full Text] [Related]
55. Serologic analysis of the lac + hybrid of Escherichia coli K-12 HFRC and variant Y of Shigella flexneri. Kolodynski J Arch Immunol Ther Exp (Warsz); 1971; 19(6):743-8. PubMed ID: 4946992 [No Abstract] [Full Text] [Related]
57. A comparative study on Shigella flexneri converting phages. Kétyi I; Vertényi A; Financsek I Acta Microbiol Acad Sci Hung; 1972; 19(3):159-74. PubMed ID: 4132169 [No Abstract] [Full Text] [Related]
58. Synthesis of two linear PADRE conjugates bearing a deca- or pentadecasaccharide B epitope as potential synthetic vaccines against Shigella flexneri serotype 2a infection. Bélot F; Guerreiro C; Baleux F; Mulard LA Chemistry; 2005 Feb; 11(5):1625-35. PubMed ID: 15669066 [TBL] [Abstract][Full Text] [Related]
59. Membrane vesicles derived from Pseudomonas aeruginosa and Shigella flexneri can be integrated into the surfaces of other gram-negative bacteria. Kadurugamuwa JL; Beveridge TJ Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2051-2060. PubMed ID: 10463171 [TBL] [Abstract][Full Text] [Related]
60. Demonstration of cross-reactivity between bacterial antigens and class I human leukocyte antigens by using monoclonal antibodies to Shigella flexneri. Williams KM; Raybourne RB Infect Immun; 1990 Jun; 58(6):1774-81. PubMed ID: 2187807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]